Related Experiment Videos
The Friedewald formula underestimates LDL cholesterol at low concentrations
H Scharnagl1, M Nauck, H Wieland
1Department of Medicine, Albert Ludwigs University, Freiburg i Br, Germany. hubsch@med1.ukl.uni-freiburg.de
Clinical Chemistry and Laboratory Medicine
|July 4, 2001
Summary
The Friedewald formula underestimates low-density lipoprotein (LDL) cholesterol levels, especially in patients undergoing LDL apheresis. This inaccuracy impacts monitoring lipid-lowering drug effectiveness and hypercholesterolemia treatment.
Area of Science:
- Clinical Chemistry
- Cardiovascular Medicine
- Biochemistry
Background:
- Recent advancements enable lower low-density lipoprotein (LDL) cholesterol targets.
- The Friedewald formula is commonly used for indirect LDL cholesterol measurement.
- Accurate LDL cholesterol monitoring is crucial for managing hypercholesterolemia.
Purpose of the Study:
- To evaluate the accuracy of the Friedewald formula at very low LDL cholesterol concentrations.
- To compare Friedewald formula results with beta-quantification in patients treated with LDL apheresis.
Main Methods:
- Analysis of 176 samples from patients undergoing LDL apheresis.
- Comparison of Friedewald formula-derived LDL cholesterol with beta-quantification.
- Assessment of bias at varying low LDL cholesterol levels.
Main Results:
- The Friedewald formula showed a significant negative bias at lower LDL cholesterol concentrations.
- Bias ranged from -18.5% at 1.58 mmol/l to -3.8% at 4.67 mmol/l.
- Underestimation increased as LDL cholesterol levels decreased.
Conclusions:
- The Friedewald formula's reliability is questionable for very low LDL cholesterol levels, such as those achieved with LDL apheresis.
- Findings suggest potential implications for monitoring patients on lipid-lowering therapies.
- Alternative methods may be needed for precise LDL cholesterol assessment in specific patient groups.